Bo Franzén

6PUBLICATIONS
24CO-AUTHORS
Liquid biopsiesMolecular targetsMedical biotechnology diagnostics (incl. biosensors)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 08, 2026
Economic value and clinical role of minimally invasive, biopsy-based diagnostics in non-small cell lung cancer.

|Jan 25, 2026
Profiling of Extracellular Vesicles of Non-Small Cell Lung Cancer Reveals Proteins Associated With Osimertinib Resistance.

Albano Cáceres-Verschae, Petra Hååg, Sofia Joelsson

|Mar 23, 2024
Minimally invasive biopsy-based diagnostics in support of precision cancer medicine.

Bo Franzén, Gert Auer, Rolf Lewensohn

|Feb 25, 2023
Multiplex protein analysis and ensemble machine learning methods of fine needle aspirates from prostate cancer patients reveal potential diagnostic signatures associated with tumour grade.

Pontus Röbeck, Bo Franzén, Rafaele Cantera-Ahlman

|Jul 15, 2022
Profiling of extracellular vesicles of metastatic urothelial cancer patients to discover protein signatures related to treatment outcome.

Kristina Viktorsson, Petra Hååg, Carl-Henrik Shah

|Mar 26, 2021
Multiplex immune protein profiling of fine-needle aspirates from patients with non-small-cell lung cancer reveals signatures associated with PD-L1 expression and tumor stage.

Bo Franzén, Kristina Viktorsson, Caroline Kamali

Pageof 1

Frequent Collaborators

5 joint publications

Rolf Lewensohn

4 joint publications

Kristina Viktorsson

3 joint publications

Petra Hååg

2 joint publications

Per Hydbring